Kidney Fibrosis Pipeline Report 2016 - Review of 21 Companies & their Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Kidney Fibrosis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Kidney Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Fibrosis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Kidney Fibrosis Overview
  3. Therapeutics Development
  4. Pipeline Products for Kidney Fibrosis - Overview
  5. Pipeline Products for Kidney Fibrosis - Comparative Analysis
  6. Kidney Fibrosis - Therapeutics under Development by Companies
  7. Kidney Fibrosis - Therapeutics under Investigation by Universities/Institutes
  8. Kidney Fibrosis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Kidney Fibrosis - Products under Development by Companies
  13. Kidney Fibrosis - Products under Investigation by Universities/Institutes
  14. Kidney Fibrosis - Companies Involved in Therapeutics Development
  • AbbVie Inc.
  • Angion Biomedica Corp.
  • Bio-inRen
  • BiOrion Technologies B.V.
  • Epigen Biosciences, Inc.
  • Evotec AG
  • Galectin Therapeutics, Inc.
  • GenKyoTex S.A.
  • GNI Group Ltd.
  • Intercept Pharmaceuticals, Inc.
  • Isarna Therapeutics GmbH
  • Lpath, Inc.
  • MorphoSys AG
  • Pharmaxis Limited
  • ProMetic Life Sciences Inc.
  • Raptor Pharmaceutical Corp.
  • Regulus Therapeutics Inc.
  • SciFluor Life Sciences, LLC
  • Symic Biomedical, Inc.
  • Tobira Therapeutics, Inc.
  • Vascular Biogenics Ltd.

For more information visit http://www.researchandmarkets.com/research/mdnlv2/kidney_fibrosis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Liver and Kidney Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Liver and Kidney Disorders Drugs